BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2157922)

  • 21. Differential effects of isoquinolinesulfonamide protein kinase inhibitors on CA1 responses in hippocampal slices.
    Leahy JC; Vallano ML
    Neuroscience; 1991; 44(2):361-70. PubMed ID: 1658681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of protein kinase inhibitors on lymphocyte blastogenesis and GVHD-induced splenomegaly.
    Wepsic HT; Duffie GP; Ellis NK
    Immunopharmacol Immunotoxicol; 1989; 11(1):81-99. PubMed ID: 2760415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of protein kinase inhibitors 1(5-isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride (H-7) and N-[2-guanidinoethyl]-5-isoquinolinesulfonamide hydrochloride (HA1004) on calcitriol-induced differentiation of HL-60 cells.
    Martell RE; Simpson RU; Hsu T
    Biochem Pharmacol; 1988 Feb; 37(4):635-40. PubMed ID: 3422561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of protein kinase inhibitors in an assay system containing multiple protein kinase activities.
    Li PM; Fukazawa H; Mizuno S; Uehara Y
    Anticancer Res; 1993; 13(6A):1957-64. PubMed ID: 8297101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein biosynthesis in B lymphocytes: induction of protein N-glycosylation, RNA synthesis, and DNA synthesis by phorbol ester plus ionomycin is blocked by protein kinase inhibitors.
    Rush JS; Snow EC; Waechter CJ
    Arch Biochem Biophys; 1988 Nov; 267(1):305-16. PubMed ID: 2461680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cytotoxic T lymphocyte-mediated lysis and cellular proliferation by isoquinoline sulfonamide protein kinase inhibitors. Evidence for the involvement of protein kinase C in lymphocyte function.
    Juszczak RJ; Russell JH
    J Biol Chem; 1989 Jan; 264(2):810-5. PubMed ID: 2783420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of a cytoplasmic activator of DNA synthesis in lymphocytes is mediated through a membrane-associated protein kinase.
    Autieri MV; Fresa KL; Coffman FD; Katz ME; Cohen S
    Cell Regul; 1990 Dec; 1(13):1015-25. PubMed ID: 1725128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase A inhibitors enhance radiation-induced apoptosis.
    Findik D; Song Q; Hidaka H; Lavin M
    J Cell Biochem; 1995 Jan; 57(1):12-21. PubMed ID: 7536751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protein kinase C inhibitor H-7, inhibits antigen and IL-2-induced proliferation of murine T cell lines.
    Clark RB; Love JT; Sgroi D; Lingenheld EG; Sha'afi RI
    Biochem Biophys Res Commun; 1987 Jun; 145(2):666-72. PubMed ID: 2439080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C (PKC) inhibitors inhibit primary (1-0) but not secondary (1-1) or cloned cytotoxic T lymphocytes.
    Howcroft TK; Tatum SM; Cosgrove JM; Lindquist RR
    Biochem Biophys Res Commun; 1988 Aug; 154(3):1280-6. PubMed ID: 3261585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase inhibitors.
    Hidaka H; Kobayashi R
    Essays Biochem; 1994; 28():73-97. PubMed ID: 7925321
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
    Hubbell HR; Boyer JE; Roane P; Burch RM
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):906-10. PubMed ID: 1846967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible roles of protein kinases in neutrophil chemotactic factor production by leucocytes in allergic inflammation in rats.
    Tanabe J; Watanabe M; Kondoh S; Mue S; Ohuchi K
    Br J Pharmacol; 1994 Dec; 113(4):1480-6. PubMed ID: 7889305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molecular pharmacology of intracellular calcium signaling].
    Hidaka H; Kobayashi R
    Seikagaku; 1990 Dec; 62(12):1473-89. PubMed ID: 1964952
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of protein kinase activities in rabbit ciliary processes: identification and characterization using exogenous substrates.
    Yoshimura N; Mittag TW; Podos SM
    Exp Eye Res; 1987 Jul; 45(1):45-56. PubMed ID: 3477466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reverse relationship between malignancy and cyclic AMP-dependent protein kinase activity in Yoshida rat ascites hepatomas.
    Miyamoto K; Nakamura S; Nomura M; Yamamoto H; Sanae F; Hidaka H
    Cancer Lett; 1993 Aug; 72(3):179-82. PubMed ID: 8402589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C involvement in focal adhesion formation.
    Woods A; Couchman JR
    J Cell Sci; 1992 Feb; 101 ( Pt 2)():277-90. PubMed ID: 1629245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium-dependent protein kinase activity is decreased in diabetic rat sciatic nerve.
    Gabbay RA; Siconolfi-Baez L; Lebovitz HE
    Endocrinology; 1990 Sep; 127(3):1194-8. PubMed ID: 2387254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer and lectin-dependent cytotoxic activities of Kurloff cells: target cell selectivity, conjugate formation, and Ca++ dependency.
    Pouliot N; Maghni K; Blanchette F; Cironi L; Sirois P; Stankova J; Rola-Pleszczynski M
    Inflammation; 1996 Dec; 20(6):647-71. PubMed ID: 8979153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fluorescent protein kinase C inhibitor: 1-(1-hydroxy-5-isoquinolinylsulfonyl)piperazine.
    Hagiwara M; Inagaki M; Takahashi J; Yoshida T; Hidaka H
    Pharmacology; 1988; 36(6):365-70. PubMed ID: 3420158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.